Tags

Type your tag names separated by a space and hit enter

[Clinical and immunological aspects of surgical treatment of stomach and duodenal ulcer].
Klin Khir. 1994KK

Abstract

Of 182 examined patients with the stomach and duodenum ulcer disease (UD) 104 (57.14%) of whom with complications. Antiulcerous antibodies were determined in patients according to results obtained in passive hemagglutination reaction (PHAR) using erythrocytic diagnosticums. In patients with gastric and duodenal UD the antitissue antibodies to corresponding antigens from gastric and duodenal ulcers were determined before the operation. The incidence of antibodies discovery depends on the patients condition. In 18 months after the operation the percentage of PHAR positive results have reduced down to 72.5% on average.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
English Abstract
Journal Article

Language

rus

PubMed ID

7707661

Citation

Shaposhnikov, A V., et al. "[Clinical and Immunological Aspects of Surgical Treatment of Stomach and Duodenal Ulcer]." Klinicheskaia Khirurgiia, 1994, pp. 9-11.
Shaposhnikov AV, Moskalenko EP, Matveev NV. [Clinical and immunological aspects of surgical treatment of stomach and duodenal ulcer]. Klin Khir. 1994.
Shaposhnikov, A. V., Moskalenko, E. P., & Matveev, N. V. (1994). [Clinical and immunological aspects of surgical treatment of stomach and duodenal ulcer]. Klinicheskaia Khirurgiia, (8), 9-11.
Shaposhnikov AV, Moskalenko EP, Matveev NV. [Clinical and Immunological Aspects of Surgical Treatment of Stomach and Duodenal Ulcer]. Klin Khir. 1994;(8)9-11. PubMed PMID: 7707661.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Clinical and immunological aspects of surgical treatment of stomach and duodenal ulcer]. AU - Shaposhnikov,A V, AU - Moskalenko,E P, AU - Matveev,N V, PY - 1994/1/1/pubmed PY - 1994/1/1/medline PY - 1994/1/1/entrez SP - 9 EP - 11 JF - Klinicheskaia khirurgiia JO - Klin Khir IS - 8 N2 - Of 182 examined patients with the stomach and duodenum ulcer disease (UD) 104 (57.14%) of whom with complications. Antiulcerous antibodies were determined in patients according to results obtained in passive hemagglutination reaction (PHAR) using erythrocytic diagnosticums. In patients with gastric and duodenal UD the antitissue antibodies to corresponding antigens from gastric and duodenal ulcers were determined before the operation. The incidence of antibodies discovery depends on the patients condition. In 18 months after the operation the percentage of PHAR positive results have reduced down to 72.5% on average. UR - https://www.unboundmedicine.com/medline/citation/7707661/[Clinical_and_immunological_aspects_of_surgical_treatment_of_stomach_and_duodenal_ulcer]_ DB - PRIME DP - Unbound Medicine ER -